Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wise, R.
Right arrow Articles by Symonds, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wise, R.
Right arrow Articles by Symonds, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2001) 48, 0III-0iii
© 2001 The British Society for Antimicrobial Chemotherapy


Supplement

Preface

Richard Wise, David Livermore, Derek Brown and Jane Symonds

Abstract

It is over 12 years since the BSAC Working Party on Susceptibility (then Sensitivity) Testing first reported its recommendations. The primary aim of the Working Party has not changed, namely to guide the hospital laboratory in ‘assisting the clinician in his/her choice of an appropriate . . . antibiotic’. In addition, the accurate surveillance of antimicrobial resistance is increasing in importance. This latest publication moves forward from the initial discussion of breakpoints in 1988, through minimum inhibitory concentration methodology in 1991 to the current standardized disc technique (and related issues such as automation, ß-lactamase detection and interpretative reading). We realize that this has involved a mammoth amount of work by a few committed individuals, who, in turn, are very grateful to the BSAC for underwriting this effort with the necessary financial resources. Equally, it has involved a wider group of interested laboratories that field-tested the method.

Some of the information in this supplement has been posted on the BSAC website (http://www.bsac.org.uk). It will be updated regularly. We advise all interested, both laboratory workers and pharmaceutical companies, to look at the website frequently.

In bringing together this Supplement we thank Sheila Dutta Chowdhury for secretarial input and most significantly all the members of the Working Party, past and present, for their hard work.

Where will we be in another 12 years? Undoubtedly automation will play a major role in the clinical laboratory and most probably detection of the genetic basis of resistance in individual isolates will be available. Until then, we commend this document to the membership of the BSAC and to a wider audience.

Notes

Birmingham, June 2001


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.